- Home
- ABEO vs OPRT Comparison
ABEO vs OPRT Comparison
Compare ABEO & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- OPRT
- Stock Information
- Founded
- ABEO 1974
- OPRT 2005
- Country
- ABEO United States
- OPRT United States
- Employees
- ABEO N/A
- OPRT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- OPRT Finance: Consumer Services
- Sector
- ABEO Health Care
- OPRT Finance
- Exchange
- ABEO Nasdaq
- OPRT Nasdaq
- Market Cap
- ABEO 281.0M
- OPRT 312.5M
- IPO Year
- ABEO 1980
- OPRT 2019
- Fundamental
- Price
- ABEO $4.36
- OPRT $5.21
- Analyst Decision
- ABEO Strong Buy
- OPRT Sell
- Analyst Count
- ABEO 5
- OPRT 2
- Target Price
- ABEO $18.20
- OPRT $6.00
- AVG Volume (30 Days)
- ABEO 1.5M
- OPRT 572.4K
- Earning Date
- ABEO 11-13-2025
- OPRT 11-04-2025
- Dividend Yield
- ABEO N/A
- OPRT N/A
- EPS Growth
- ABEO N/A
- OPRT N/A
- EPS
- ABEO 0.99
- OPRT 0.66
- Revenue
- ABEO $400,000.00
- OPRT $712,617,000.00
- Revenue This Year
- ABEO N/A
- OPRT $26.95
- Revenue Next Year
- ABEO $324.71
- OPRT $5.74
- P/E Ratio
- ABEO $4.41
- OPRT $7.94
- Revenue Growth
- ABEO N/A
- OPRT N/A
- 52 Week Low
- ABEO $3.93
- OPRT $2.62
- 52 Week High
- ABEO $7.54
- OPRT $9.25
- Technical
- Relative Strength Index (RSI)
- ABEO 24.72
- OPRT 40.56
- Support Level
- ABEO $5.29
- OPRT $5.12
- Resistance Level
- ABEO $5.41
- OPRT $5.46
- Average True Range (ATR)
- ABEO 0.24
- OPRT 0.26
- MACD
- ABEO -0.08
- OPRT 0.01
- Stochastic Oscillator
- ABEO 3.49
- OPRT 23.17
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.